PMID- 34857723 OWN - NLM STAT- MEDLINE DCOM- 20220211 LR - 20230829 IS - 1539-2570 (Electronic) IS - 0271-6798 (Linking) VI - 42 IP - 3 DP - 2022 Mar 1 TI - Predictors of Achieving the Patient Acceptable Symptomatic State at Minimum 5-Year Follow-up Following Primary Hip Arthroscopy in the Adolescent Athlete. PG - e277-e284 LID - 10.1097/BPO.0000000000002022 [doi] AB - BACKGROUND: Predictors of outcomes in adolescent athletes undergoing hip arthroscopy have not been established. The purpose of this study was to identify factors correlated with achieving the Patient Acceptable Symptomatic State (PASS) for the Hip Outcome Score-Sports Specific Subscale (HOS-SSS) at a minimum 5-year follow-up in adolescent athletes undergoing primary hip arthroscopy. METHODS: Data were reviewed on adolescent (below 18 y old) athletes who underwent primary hip arthroscopy for femoroacetabular impingement syndrome between March 2008 and October 2015. Patients were included if they participated in sport within 1 year before surgery and had preoperative, 2-year, and minimum 5-year postoperative patient-reported outcome (PRO) scores for the modified Harris Hip Score, HOS-SSS, Visual Analog Scale for pain (VAS), and Non-Arthritic Hip Score (NAHS). Patients were divided into 2 groups based on whether they achieved PASS for HOS-SSS. Demographics, intraoperative findings, radiographic variables, surgical treatments, and PRO were compared. Multivariate logistic regression with corresponding odds ratios (ORs) quantified the correlation between variables and achievement of the PASS. RESULTS: A total of 123 athletes with a mean age of 16.2+/-1.1 years were included. These athletes demonstrated significant imrpovement from preoperative to minimum 5-year follow-up for all recorded PROs (P<0.001). The multivariate logistic regression model identified preoperative NAHS (P=0.019, OR: 1.033), 2-year postoperative HOS-SSS (P=0.014, OR: 1.037), and 2-year postoperative VAS (P=0.003, OR: 0.590) as statistically significantly correlated with achieving the PASS. Athletes with a 2-year postoperative VAS pain score 2 achieved PASS at a rate of 24.1% (P<0.001, OR: 14.2, 95% confidence interval: 5.23-38.7). CONCLUSIONS: Favorable outcome were achieved at mid-term follow-up in adolescent athletes undergoing primary hip arthroscopy. Preoperative NAHS, 2-year postoperative HOS-SSS, and 2-year postoperative VAS pain scores were correlated with achieving the PASS for HOS-SSS at a minimum 5-year follow-up. Patients with 2-year postoperative VAS 2. LEVEL OF EVIDENCE: Level III-case-control study. CI - Copyright (c) 2021 Wolters Kluwer Health, Inc. All rights reserved. FAU - Jimenez, Andrew E AU - Jimenez AE AD - American Hip Institute Research Foundation. FAU - Glein, Rachel M AU - Glein RM AD - American Hip Institute Research Foundation. FAU - Owens, Jade S AU - Owens JS AD - American Hip Institute Research Foundation. FAU - Lee, Michael S AU - Lee MS AD - American Hip Institute Research Foundation. FAU - Maldonado, David R AU - Maldonado DR AD - American Hip Institute Research Foundation. FAU - Saks, Benjamin R AU - Saks BR AD - American Hip Institute Research Foundation. AD - AMITA Health St. Alexius Medical Center, Hoffman Estates, IL. FAU - Lall, Ajay C AU - Lall AC AD - American Hip Institute Research Foundation. AD - American Hip Institute, Chicago. AD - AMITA Health St. Alexius Medical Center, Hoffman Estates, IL. FAU - Domb, Benjamin G AU - Domb BG AD - American Hip Institute Research Foundation. AD - American Hip Institute, Chicago. AD - AMITA Health St. Alexius Medical Center, Hoffman Estates, IL. LA - eng PT - Journal Article PL - United States TA - J Pediatr Orthop JT - Journal of pediatric orthopedics JID - 8109053 SB - IM MH - Activities of Daily Living MH - Adolescent MH - *Arthroscopy MH - Athletes MH - Case-Control Studies MH - *Femoracetabular Impingement/diagnostic imaging/surgery MH - Follow-Up Studies MH - Hip Joint/diagnostic imaging/surgery MH - Humans MH - Retrospective Studies MH - Treatment Outcome COIS- B.G.D. reports grants and other from American Orthopedic Foundation, during the conduct of the study; personal fees from Adventist Hinsdale Hospital; personal fees and nonfinancial support from Amplitude; grants, personal fees, and nonfinancial support from Arthrex; personal fees and nonfinancial support from DJO Global; grants from Kaufman Foundation; grants, personal fees, nonfinancial support from Medacta; grants, personal fees, nonfinancial support, and other from Pacira Pharmaceuticals; grants, personal fees, nonfinancial support, and other from Stryker; grants from Breg; personal fees from Orthomerica; grants, personal fees, nonfinancial support, and other from Mako Surgical Corp.; grants and nonfinancial support from Medwest Associates; grants from ATI Physical Therapy; grants, personal fees, and nonfinancial support from St. Alexius Medical Center; grants from Ossur, outside the submitted work. In addition, He has a patent 8920497-Method and instrumentation for acetabular labrum reconstruction with royalties paid to Arthrex; a patent 8708941-Adjustable multicomponent hip orthosis with royalties paid to Orthomerica and DJO Global; and a patent 9737292-Knotless suture anchors and methods of tissue repair with royalties paid to Arthrex. B.G.D. is the Medical Director of Hip Preservation at St. Alexius Medical Center; the Clinical Instructor at the University of Illinois College of Medicine; a board member for the American Hip Institute Research Foundation, AANA Learning Center Committee, the Journal of Hip Preservation Surgery, the Journal of Arthroscopy; has had ownership interests in the American Hip Institute, Hinsdale Orthopedic Associates, Hinsdale Orthopedic Imaging, SCD#3, North Shore Surgical Suites, and Munster Specialty Surgery Center. A.C.L. reports grants, personal fees, and nonfinancial support from Arthrex; nonfinancial support from Iroko; nonfinancial support from Medwest; nonfinancial support from Smith & Nephew; grants and nonfinancial support from Stryker; nonfinancial support from Vericel; nonfinancial support from Zimmer Biomet; personal fees from Graymont Medical, outside the submitted work. He is the Co-Medical Director of Hip Preservation at St. Alexius Medical Center; the Clinical Instructor at the University of Illinois College of Medicine; and member of the AANA Learning Center Committee. B.R.S. reports grants from Arthrex; personal fees from DJO Global, outside the submitted work. D.R.M. reports nonfinancial support from Arthrex; nonfinancial support from Stryker; nonfinancial support from Smith & Nephew; nonfinancial support from Ossur, outside the submitted work. He is an editorial board member of the Journal of Arthroscopy. The remaining authors declare no conflicts of interest. EDAT- 2021/12/04 06:00 MHDA- 2022/02/12 06:00 CRDT- 2021/12/03 06:13 PHST- 2021/12/04 06:00 [pubmed] PHST- 2022/02/12 06:00 [medline] PHST- 2021/12/03 06:13 [entrez] AID - 01241398-202203000-00014 [pii] AID - 10.1097/BPO.0000000000002022 [doi] PST - ppublish SO - J Pediatr Orthop. 2022 Mar 1;42(3):e277-e284. doi: 10.1097/BPO.0000000000002022.